Measuring and targeting aldosterone and renin in atherosclerosis—A review of clinical data

This publication has 109 references indexed in Scilit:

• Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
  New England Journal of Medicine, 2011
• Managing cardiovascular and renal risk: the potential of direct renin inhibition
  Journal of the Renin-Angiotensin-Aldosterone System, 2009
• Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction
  European Heart Journal, 2008
• Renin Inhibition by Aliskiren Prevents Atherosclerosis Progression
  Hypertension, 2008
• Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors
  Journal Of Hypertension, 2008
• High Plasma Aldosterone Levels on Admission Are Associated With Death in Patients Presenting With Acute ST-Elevation Myocardial Infarction
  Circulation, 2006
• Carotid Intima-Media Thickness and Antihypertensive Treatment
  Stroke, 2006
• Eplerenone Inhibits Atherosclerosis in Nonhuman Primates
  Hypertension, 2005
• The angiotensin II receptor blocker candesartan cilexetil reduces neointima proliferation after coronary stent implantation
  American Heart Journal, 2005
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999